Company profile MRTX
After 39 days of this quarter the interest is at 59.0. Based on that we can calculate that during remaining 52 days it will total up to 138.0. Mirati Therapeutics expected interest is significantly higher compared to same quarter last year (+97.1%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 32 | 99 209.4% QoQ | 40 -59.6% QoQ | 69 72.5% QoQ |
| 2020 | 62 93.8% YoY -10.1% QoQ | 75 -24.2% YoY 21.0% QoQ | 44 10.0% YoY -41.3% QoQ | 54 -21.7% YoY 22.7% QoQ |
| 2021 | 69 11.3% YoY 27.8% QoQ | 63 -16.0% YoY -8.7% QoQ | 72 63.6% YoY 14.3% QoQ | 86 59.3% YoY 19.4% QoQ |
| 2022 | 88 27.5% YoY 2.3% QoQ | 85 34.9% YoY -3.4% QoQ | 73 1.4% YoY -14.1% QoQ | 95 10.5% YoY 30.1% QoQ |
| 2023 | 70 -20.5% YoY -26.3% QoQ | 72 -15.3% YoY 2.9% QoQ | 86 17.8% YoY 19.4% QoQ | 170 78.9% YoY 97.7% QoQ |
| 2024 | 59 -15.7% YoY -65.3% QoQ | - | - | - |
The average 5 years interest of Mirati Therapeutics was 5.99 per week. The last year interest of Mirati Therapeutics compared to the last 5 years has changed by 34.22%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 52.56%.
After 39 days of this quarter the interest is at 198.0. Based on that we can calculate that during remaining 52 days it will total up to 462.0. Mirati Therapeutics stock expected interest is significantly higher compared to previous quarter (+111.9%) and same quarter last year (+484.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 43 | 248 476.7% QoQ | 156 -37.1% QoQ | 201 28.8% QoQ |
| 2020 | 169 293.0% YoY -15.9% QoQ | 151 -39.1% YoY -10.7% QoQ | 99 -36.5% YoY -34.4% QoQ | 183 -9.0% YoY 84.8% QoQ |
| 2021 | 174 3.0% YoY -4.9% QoQ | 259 71.5% YoY 48.9% QoQ | 28 -71.7% YoY -89.2% QoQ | 314 71.6% YoY 1021.4% QoQ |
| 2022 | 135 -22.4% YoY -57.0% QoQ | 272 5.0% YoY 101.5% QoQ | 108 285.7% YoY -60.3% QoQ | 228 -27.4% YoY 111.1% QoQ |
| 2023 | 79 -41.5% YoY -65.4% QoQ | 180 -33.8% YoY 127.8% QoQ | 175 62.0% YoY -2.8% QoQ | 218 -4.4% YoY 24.6% QoQ |
| 2024 | 198 150.6% YoY -9.2% QoQ | - | - | - |
The average 5 years interest of Mirati Therapeutics stock was 13.86 per week. The last year interest of Mirati Therapeutics stock compared to the last 5 years has changed by 7.0%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 2.42%.
After 39 days of this quarter the interest is at 47.0. Based on that we can calculate that during remaining 52 days it will total up to 110.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 101 | 103 2.0% QoQ | 47 -54.4% QoQ | 109 131.9% QoQ |
| 2020 | 79 -21.8% YoY -27.5% QoQ | 35 -66.0% YoY -55.7% QoQ | 283 502.1% YoY 708.6% QoQ | 186 70.6% YoY -34.3% QoQ |
| 2021 | 165 108.9% YoY -11.3% QoQ | 112 220.0% YoY -32.1% QoQ | 164 -42.0% YoY 46.4% QoQ | 37 -80.1% YoY -77.4% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 55 -50.9% YoY inf% QoQ | 85 -48.2% YoY 54.5% QoQ | 96 159.5% YoY 12.9% QoQ |
| 2023 | 134 inf% YoY 39.6% QoQ | 32 -41.8% YoY -76.1% QoQ | 108 27.1% YoY 237.5% QoQ | 100 4.2% YoY -7.4% QoQ |
| 2024 | 47 -64.9% YoY -53.0% QoQ | - | - | - |
The average 5 years interest of Mirati Therapeutics news was 7.96 per week. The last year interest of Mirati Therapeutics news compared to the last 5 years has changed by -5.78%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -1.57%.
There is not enough data for KRAZATI drug to provide analysis
There is not enough data for KRAZATI drug to provide correlation calculation
There is not enough data for KRAZATI drug to provide analysis
There is not enough data for Sitravatinib drug to provide analysis
There is not enough data for Sitravatinib drug to provide correlation calculation
There is not enough data for Sitravatinib drug to provide analysis
There is not enough data for Mirati Therapeutics clinical trials to provide analysis
There is not enough data for Mirati Therapeutics clinical trials to provide correlation calculation
There is not enough data for Mirati Therapeutics clinical trials to provide analysis
There is not enough data for Mirati Therapeutics pipeline to provide analysis
There is not enough data for Mirati Therapeutics pipeline to provide correlation calculation
There is not enough data for Mirati Therapeutics pipeline to provide analysis
There is not enough data for Mirati Therapeutics headquarters to provide analysis
There is not enough data for Mirati Therapeutics headquarters to provide correlation calculation
There is not enough data for Mirati Therapeutics headquarters to provide analysis
There is not enough data for Mirati Therapeutics contact to provide analysis
There is not enough data for Mirati Therapeutics contact to provide correlation calculation
There is not enough data for Mirati Therapeutics contact to provide analysis